Pfizer Inc. today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 MagnetisMM-5 study evaluating ELREXFIO® (elranatamab) as monotherapy ...

OpenAI Foundation pledges $100 million to Alzheimer’s research, highlighting AI’s potential to accelerate diagnosis, drug ...

Lund University. The award is presented every two years to a researcher who has made outstanding contributions to transfusion ...

Discover 100 facts that will mess with your brain! Explore mind-bending truths about your body, animals, and history. Prepare ...

The body’s “killer” T cells don’t just attack—they strike with astonishing precision, forming a tiny, highly organized ...

A detailed new map of the human kidney revealed a previously unrecognized form of diabetic kidney disease (DKD) marked by ...

Cytotoxic T lymphocytes are the body's specialized "killer" cells, precisely eliminating infected or cancerous cells.

A detailed new map of the human kidney revealed a previously unrecognized form of diabetic kidney disease (DKD) marked by ...

Google tracks the vast majority of cellphones in the United States, collecting your location, usage and device data through installed software and apps. The tracking occurs by various autonomous ...

Recent research highlights breakthroughs in infectious disease diagnostics, from metagenomic sequencing and CRISPR-based detection to graphene nanodrums that identify bacteria by sound. Innovations in ...

Objective: To evaluate the detection performance of microfluidic chip-based multiplex PCR technology for rapid detection of ...